Maiwald Magazine

Maiwald Blog

All articles

Press Coverage

7 Jan 2022 - Press Coverage

Royalty Pharma and Cytokinetics Announce Funding Agreements Totaling up to $450 Million

Royalty Pharma Extends Capital to Cytokinetics to Support the Commercial Launch of Omecamtiv Mecarbil and the Further Development of AficamtenRoyalty Pharma Purchases Royalties on Future Sales of Aficamten

22 Nov 2021 - Press Coverage

Royalty Pharma Acquires Additional Royalty Interests in bcx9930 and Orladeyo From Biocryst Pharmaceuticals

Royalty Pharma plc (Nasdaq: RPRX), BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and OMERS Capital Markets (OMERS) today announced transactions totaling $350 million in new funding for BioCryst, with all funds immediately available at closing.

4 Oct 2021 - Press Coverage

Maiwald Appoints Heike Röder-Hitschke as Counsel

On July 1, 2019, Maiwald, one of the leading intellectual property law firms in Germany, named Heike Röder-Hitschke as Counsel. Heike Röder-Hi...

Maiwald in the press

Staff News

16 Jul 2021 - Staff News

Maiwald Appoints Dr Annelie Wünsche as Partner

Maiwald, one of Germany’s leading IP law firms, has appointed

4 Mar 2021 - Staff News

Maiwald appoints three new counsels

With effect from 1 March 2021, Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH, one of Germany's leading IP firms, appointed three of its Munich patent attorneys to&n...

20 Jul 2020 - Staff News

Maiwald appoints Dr. Andreas Eisele as Counsel

Maiwald, one of the leading German patent law firms, has appointed Andreas Eisele, a ...

Staff News

Publications

11 Jan 2022 - Publication

News from the EPO: The new Guidelines for Examination 2021 and Videoconferences

by Dr Naho Fujimoto in AIPPI

2 Nov 2021 - Publication

2nd Edition of the Handbook “The Supplementary Protection Certificates (SPC)”

We are delighted to announce the release of the 2nd Edition of the Handbook “The Supplementary Protection Certificates (SPC)” edited by our partner

2 Nov 2021 - Publication

JUVE Handbook 2021/2022: Co-publishing article on the topic of “Chances and stumbling blocks in video negotiations at the EPO”

In the current edition of the JUVE Handbook for Commercial Law Firms 2021/2022 published in October 2021

All publications

Awards

9 Nov 2021 - Award

Events

All events

News and Releases

Maiwald Blog

Unitary Patent System: Provisional Application of the Agreement on a Unified Patent Court (UPCA) Starts

Patent: Suspension of Infringement Proceedings in the Case of (Future) Nullity Suit

Possible Referral to the Enlarged Board of Appeal on the Applicability of the “Joint Applicants Approach” (T 1513/17)

Press Coverage

Royalty Pharma and Cytokinetics Announce Funding Agreements Totaling up to $450 Million

Royalty Pharma Acquires Additional Royalty Interests in bcx9930 and Orladeyo From Biocryst Pharmaceuticals

Maiwald Appoints Heike Röder-Hitschke as Counsel

Staff News

Maiwald Appoints Dr Annelie Wünsche as Partner

Maiwald appoints three new counsels

Maiwald appoints Dr. Andreas Eisele as Counsel

Publications

News from the EPO: The new Guidelines for Examination 2021 and Videoconferences

2nd Edition of the Handbook “The Supplementary Protection Certificates (SPC)”

JUVE Handbook 2021/2022: Co-publishing article on the topic of “Chances and stumbling blocks in video negotiations at the EPO”

Awards

Wirtschaftswoche: Top Law Firms and Top Attorney 2021

JUVE Patent 2021

JUVE Handbook German Commercial Law Firms 2021/2022

Events

Protection and Enforcement of Software Inventions in DE, KR and US

Seminar Patent Practice in Japan and EP for Protecting AI/IOT Business